Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings Stock Forecast

Stock Price Forecast

According to 27 analysts polled by S&P Global, Zimmer Biomet Holdings stock has a consensus rating of "Hold" and an average price target of $116.24. The average 1-year stock price forecast is 12.81% higher than the current stock price, while the lowest is $98 (-4.89%) and the highest is $130 (+26.16%).

Price Target: $116.24 (+12.81%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$98	$116.24	$117	$130
Change	-4.89%	+12.81%	+13.55%	+26.16%

Analyst Ratings

The average analyst rating for Zimmer Biomet Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	6	6	6	6	6	6
Buy	2	3	3	3	2	1
Hold	17	18	18	18	19	20
Sell	0	0	0	0	0	0
Strong Sell	1	0	0	0	0	0
Total	26	27	27	27	27	27

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew O'Brien Piper Sandler	Piper Sandler	Hold Maintains $110	Hold	Maintains	$110	+6.75%	Nov 9, 2026
Christopher Pasquale Barclays	Barclays	Hold Maintains $100 → $115	Hold	Maintains	$100 → $115	+11.61%	Nov 9, 2026
Richard Newitter Truist Financial	Truist Financial	Hold Maintains $106 → $114	Hold	Maintains	$106 → $114	+10.64%	Nov 5, 2026
Robbie Marcus J.P. Morgan	J.P. Morgan	Hold Maintains $117 → $120	Hold	Maintains	$117 → $120	+16.46%	Nov 5, 2026
Patrick Wood UBS	UBS	Buy Reiterates $120 → $130	Buy	Reiterates	$120 → $130	+26.16%	Nov 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

8.61B

Increased by 4.65%

from 8.23B

Revenue Next Year

8.90B

Increased by 3.30%

from 8.61B

EPS This Year

8.55

Increased by 4.21%

from 8.20

EPS Next Year

8.98

Increased by 5.05%

from 8.55

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	6.83B	6.94B	7.39B	7.68B	8.23B	8.61B
Revenue Growth	11.42%	1.65%	6.55%	3.85%	7.20%	4.65%
Gross Profit	4.87B	4.92B	5.32B	5.50B	5.74B	6.19B
Gross Margin	71.29%	70.90%	71.93%	71.61%	69.71%	71.82%
Operating Income	1.22B	1.29B	1.51B	1.59B	1.40B	2.31B
Net Income	401.60M	231.40M	1.02B	903.80M	705.10M	940.59M
EPS	-	-	-	-	8.20	8.55
EPS Growth	-	-	-	-	2.50%	4.21%
Forward PE	16.40	18.63	15.47	12.52	10.72	12.06
Dividend / Share	0.96	0.96	0.96	0.96	0.96	0.99
Dividend Growth	-	-	-	-	-	3.11%
Free Cash Flow	-	-	-	-	1.17B	1.27B
No. Analysts	-	-	-	-	-	25

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	8.6B
Avg	8.6B
Low	8.6B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	4.8%
Avg	4.6%
Low	4.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	8.60
Avg	8.55
Low	8.30

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	4.9%
Avg	4.2%
Low	1.2%

Data Sources: S&P Global Market Intelligence and TipRanks Last updated: Nov 9, 2026

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Individual analyst data is provided by TipRanks. Price targets and consensus ratings update every hour to every three days, while individual analyst data updates in near real-time.

Last checked:

Nov 9, 2026

Data Sources Report a data error